Thus, in 66.7% of CRC cases and only in 12.25% of colorectal adenoma cases, a positive reaction to the HIF-1α protein was observed in an immunohistochemical study; it was predominantly detected in the cytoplasm of cells localized around the necrosis areas and in the areas of angiogenesis. This evidence concerns the gene HIF1A and colorectal carcinoma.